Pyrls vs Figma
Side-by-side comparison of AI visibility scores, market position, and capabilities
Modern mobile drug reference app for prescribers with dosing, interactions, and patient education; 50K+ healthcare providers from YC-backed competing with Epocrates for clinical decision support.
About
Pyrls is a Minneapolis-based healthcare technology company providing a modern medical drug reference app that enables clinicians, pharmacists, and healthcare trainees to prescribe medications, check interactions, and educate patients more effectively — delivering clinical decision support at the point of care through a mobile-first reference tool that competes with Epocrates as the go-to medication reference for healthcare providers. Founded in 2020 and backed by Y Combinator, Pyrls serves 50,000+ healthcare providers and trainees across hundreds of organizations, achieving $500,000 in revenue in 2024 with a 34-person team.
Dominant browser-based collaborative UI design platform at ~$600M ARR and $12.5B valuation; Adobe's $20B acquisition blocked by regulators in 2023, Figma remains independent competing with Sketch and Adobe.
About
Figma is a San Francisco-based collaborative web-based product design platform that has become the dominant tool for UI/UX designers and product teams — enabling real-time multi-user collaboration on interface design, prototyping, and design system management directly in the browser without installing desktop software. Founded in 2012 by Dylan Field and Evan Wallace and backed by Sequoia, Greylock, and Andreessen Horowitz with over $330 million raised, Figma generated approximately $600 million in ARR in 2023, serving 4 million+ designers and product teams at companies including Microsoft, Airbnb, Twitter, and Uber. Adobe announced a $20 billion acquisition offer in 2022, which was blocked by regulators in 2023 — Figma remains independent.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.